Quick Read: San Francisco Breast Cancer Advocates Jubilant Over Supreme Court Human Genes Ruling
The court ruled that human genes are not patentable. The case centered around Myriad Genetics, the holder of patents on two genes, BRCA 1 and BRCA 2. Some mutations of these genes are associated with an increased risk of breast and ovarian cancer. For women with a strong family history of these cancers, the only place they could be tested was Myriad Genetics, which sometimes charged more than $3,000 for the test.
Breast Cancer Action, an advocacy group based in San Francisco, was a plaintiff in the case and executive director Karuna Jaggar sounded jubilant in a phone call Thursday morning.
Read more at: blogs.kqed.org